Cisplatin resistance and opportunities for precision medicine

L Amable - Pharmacological research, 2016 - Elsevier
Cisplatin is one of the most commonly used chemotherapy drugs, treating a wide range of
cancer types. Unfortunately, many cancers initially respond to platinum treatment but when …

[引用][C] Cisplatin resistance and opportunities for precision medicine

L Amable - Pharmacological Research, 2016 - cir.nii.ac.jp
Cisplatin resistance and opportunities for precision medicine | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Cisplatin resistance and opportunities for precision medicine

L Amable - Pharmacological Research, 2016 - infona.pl
Cisplatin is one of the most commonly used chemotherapy drugs, treating a wide range of
cancer types. Unfortunately, many cancers initially respond to platinum treatment but when …

Cisplatin resistance and opportunities for precision medicine

L Amable - Pharmacological research, 2016 - pubmed.ncbi.nlm.nih.gov
Cisplatin is one of the most commonly used chemotherapy drugs, treating a wide range of
cancer types. Unfortunately, many cancers initially respond to platinum treatment but when …

Cisplatin resistance and opportunities for precision medicine.

L Amable - Pharmacological Research, 2016 - europepmc.org
Cisplatin is one of the most commonly used chemotherapy drugs, treating a wide range of
cancer types. Unfortunately, many cancers initially respond to platinum treatment but when …